Lista de obras - Tomas J. Philipson - Dominio Público Uruguay

Adjusting National Accounting for Health: Is the Business Cycle Countercyclical? ⬇️

artículo científico publicado en 2013

Aging and the Growth of Long-Term Care ⬇️

artículo científico publicado en 1999

An Economic Evaluation of the War on Cancer ⬇️

artículo científico publicado en 2009

An Empirical Examination of Information Barriers to Trade in Insurance ⬇️

artículo científico publicado en 1996

Antitrust and the Not-For-Profit Sector ⬇️

artículo científico publicado en 2001

Antitrust in the Not-For-Profit Sector ⬇️

artículo científico publicado en 2006

Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process ⬇️

artículo científico publicado en 2004

Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts ⬇️

artículo científico publicado en 2005

Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets ⬇️

artículo científico publicado en 2011

Consumption vs. Production of Insurance ⬇️

artículo científico publicado en 1997

Disease Complementarities and the Evaluation of Public Health Interventions ⬇️

artículo científico publicado en 1995

Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension ⬇️

artículo científico publicado en 2013

Economic Epidemiology and Infectious Diseases ⬇️

artículo científico publicado en 1999

Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption ⬇️

artículo científico publicado en 2009

External Treatment Effects and Program Implementation Bias ⬇️

artículo científico publicado en 2000

Financial Health Economics ⬇️

artículo científico publicado en 2014

Health Care Adherence and Personalized Medicine ⬇️

artículo científico publicado en 2014

Health Care, Technological Change, and Altruistic Consumption Externalities ⬇️

artículo científico publicado en 2006

How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations ⬇️

artículo científico publicado en 2016

Integrated Insurance Design in the Presence of Multiple Medical Technologies ⬇️

artículo científico publicado en 2007

Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets ⬇️

artículo científico publicado en 2003

Intellectual Property and Marketing ⬇️

artículo científico publicado en 2006

International Health Economics ⬇️

artículo científico publicado en 2013

Is the Food and Drug Administration Safe and Effective? ⬇️

artículo científico publicado en 2007

Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity ⬇️

artículo científico publicado en 2008

Merit Motives and Government Intervention: Public Finance in Reverse ⬇️

artículo científico publicado en 2000

Mortality Contingent Claims, Health Care, and Social Insurance ⬇️

artículo científico publicado en 1996

Nonprofit Production and Competition ⬇️

artículo científico publicado en 1998

Observational Agency and Supply-Side Econometrics ⬇️

artículo científico publicado en 1997

Public Liabilities and Health Care Policy ⬇️

artículo científico publicado en 2012

Sharing R&D Risk in Healthcare via FDA Hedges ⬇️

artículo científico publicado en 2017

Surplus Appropriation from R&D and Health Care Technology Assessment Procedures ⬇️

artículo científico publicado en 2006

Terminal Care and The Value of Life Near Its End ⬇️

article published in 2010

The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry ⬇️

artículo científico publicado en 2002

The Effects of Product Liability Exemption in the Presence of the FDA ⬇️

artículo científico publicado en 2009

The Future of Old-Age Longevity: Competitive Pricing of Mortality Contingent Claims ⬇️

artículo científico publicado en 1997

The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination ⬇️

artículo científico publicado en 2002

The Impact of Comparative Effectiveness Research on Health and Health Care Spending ⬇️

artículo científico publicado en 2010

The Long-Run Growth in Obesity as a Function of Technological Change ⬇️

artículo científico publicado en 1999

The Quantity and Quality of Life and the Evolution of World Inequality ⬇️

The Rise in Old Age Longevity and the Market for Long-Term Care ⬇️

artículo científico publicado en 1998

The Value of Life Near its End and Terminal Care ⬇️

artículo científico publicado en 2007

The Value of Life in General Equilibrium ⬇️

artículo científico publicado en 2008

Lista de obras de Tomas J. Philipson

Adjusting National Accounting for Health: Is the Business Cycle Countercyclical? ⬇️

Aging and the Growth of Long-Term Care ⬇️

An Economic Evaluation of the War on Cancer ⬇️

An Empirical Examination of Information Barriers to Trade in Insurance ⬇️

Antitrust and the Not-For-Profit Sector ⬇️

Antitrust in the Not-For-Profit Sector ⬇️

Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process ⬇️

Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts ⬇️

Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets ⬇️

Consumption vs. Production of Insurance ⬇️

Disease Complementarities and the Evaluation of Public Health Interventions ⬇️

Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension ⬇️

Economic Epidemiology and Infectious Diseases ⬇️

Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption ⬇️

External Treatment Effects and Program Implementation Bias ⬇️

Financial Health Economics ⬇️

Health Care Adherence and Personalized Medicine ⬇️

Health Care, Technological Change, and Altruistic Consumption Externalities ⬇️

How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations ⬇️

Integrated Insurance Design in the Presence of Multiple Medical Technologies ⬇️

Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets ⬇️

Intellectual Property and Marketing ⬇️

International Health Economics ⬇️

Is the Food and Drug Administration Safe and Effective? ⬇️

Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity ⬇️

Merit Motives and Government Intervention: Public Finance in Reverse ⬇️

Mortality Contingent Claims, Health Care, and Social Insurance ⬇️

Nonprofit Production and Competition ⬇️

Observational Agency and Supply-Side Econometrics ⬇️

Public Liabilities and Health Care Policy ⬇️

Sharing R&D Risk in Healthcare via FDA Hedges ⬇️

Surplus Appropriation from R&D and Health Care Technology Assessment Procedures ⬇️

Terminal Care and The Value of Life Near Its End ⬇️

The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry ⬇️

The Effects of Product Liability Exemption in the Presence of the FDA ⬇️

The Future of Old-Age Longevity: Competitive Pricing of Mortality Contingent Claims ⬇️

The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination ⬇️

The Impact of Comparative Effectiveness Research on Health and Health Care Spending ⬇️

The Long-Run Growth in Obesity as a Function of Technological Change ⬇️

The Quantity and Quality of Life and the Evolution of World Inequality ⬇️

The Rise in Old Age Longevity and the Market for Long-Term Care ⬇️

The Value of Life Near its End and Terminal Care ⬇️

The Value of Life in General Equilibrium ⬇️

Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs ⬇️